BIOCHEM BEHAV 29(3)495-500, 1988 --Male rats made dmbetlc by intravenous rejection of streptozotocm were used to evaluate the effect of the dmbetlc state on morphine-and nalmefene-mduced changes m food retake and body weight Morphme mcreased 4 hour food retake m non-dmbet~c rats after an initial rejection, but increased intake in diabetic rats only after repeated rejections Unhke short term measurements, morphine decreased food intake when measured over 24 or more hours in both groups Chronic rejection of morphine decreased body weight only m non-diabetic rats Feed efficiency data suggest that morphine had a more potent effect on energy balance m the non-dlabet~c rats The oplold antagomst, nalmefene, did not alter body weight in either group and only altered food intake m the diabetic animals These data are m concert w~th other reports indicating that the diabetic state renders animals less responsive to the effects of morphine on noocept~on and smooth muscle contraction Oplolds Dmbetes Morphine Nalmefene GLUCOSE has been shown to modulate the responsiveness of laboratory ammals to oplold effects In 1956 Davis et al [3] found that hypoglycemia potentiated the antlnoclceptlve action of morphine in rats as quantified by the tall flick method Simon et al [29, 30] demonstrated that the analgesic effects of morphine, phenazoclne and levorphanol were decreased in rats made diabetic by injection of streptozotocln Pretreatment with hypertonlc dextrose or fructose produced the same effect [29, 30] Shook et al [28] also reported that increasing the concentration of glucose in the media reduced the responsivlty of the electrically stimulated ileum to normorphine which suggests that glucose concentration, rather than insulin alteration, is the mediator of their m VlVO findings Recently, Shook and Dewey [27] found that diabetic mice were less physically dependent upon morphine than non-diabetic controls Genetically diabetic mice display Increased tall flick latencies to radiant heat relative to their httermate controls [9] Both diabetic patients and subjects refused with glucose had decreased pain thresholds and pmn tolerance [22] Since it 1s known that glucose levels or glucose utlhzatlon can modulate feeding behavior, that opioids can stimulate food intake [7, 21] and that glucose modulates oploid noclceptlve effects, ~t seems reasonable to believe that glucose might modulate oplold effects on food intake Our laboratory found that both genetically diabetic mice (C57 BL/Ks-db+/db+) and streptozotocln dtabetlc mice show enhanced sensitivity to naloxone-lnduced suppression of food intake [6] Rats made hypoglycemlc by injection of lnsuhn, a procedure that sttmulates food intake, are relatively insensitive to naloxone diminution of food intake [5, 10] , however, this may depend upon the environment in which the study IS conducted [25] In general, then, it appears that elevated glucose levels potentiate the naloxone effect, although we have found this to be markedly influenced by the animal's environment [8] Data concerning long term administration of oplold agonlsts and antagonists on food intake and body weight are few and confusing Chronic naltrexone infusions decreased food Intake in rats fed chow plus a 32% sucrose solution 1Requests for reprints should be addressed to Allen S Levlne,
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Oplolds
Dmbetes Morphine Nalmefene GLUCOSE has been shown to modulate the responsiveness of laboratory ammals to oplold effects In 1956 Davis et al [3] found that hypoglycemia potentiated the antlnoclceptlve action of morphine in rats as quantified by the tall flick method Simon et al [29, 30] demonstrated that the analgesic effects of morphine, phenazoclne and levorphanol were decreased in rats made diabetic by injection of streptozotocln Pretreatment with hypertonlc dextrose or fructose produced the same effect [29, 30] Shook et al [28] also reported that increasing the concentration of glucose in the media reduced the responsivlty of the electrically stimulated ileum to normorphine which suggests that glucose concentration, rather than insulin alteration, is the mediator of their m VlVO findings Recently, Shook and Dewey [27] found that diabetic mice were less physically dependent upon morphine than non-diabetic controls Genetically diabetic mice display Increased tall flick latencies to radiant heat relative to their httermate controls [9] Both diabetic patients and subjects refused with glucose had decreased pain thresholds and pmn tolerance [22] Since it 1s known that glucose levels or glucose utlhzatlon can modulate feeding behavior, that opioids can stimulate food intake [7, 21] and that glucose modulates oploid noclceptlve effects, ~t seems reasonable to believe that glucose might modulate oplold effects on food intake Our laboratory found that both genetically diabetic mice (C57 BL/Ks-db+/db+) and streptozotocln dtabetlc mice show enhanced sensitivity to naloxone-lnduced suppression of food intake [6] Rats made hypoglycemlc by injection of lnsuhn, a procedure that sttmulates food intake, are relatively insensitive to naloxone diminution of food intake [5, 10] , however, this may depend upon the environment in which the study IS conducted [25] In general, then, it appears that elevated glucose levels potentiate the naloxone effect, although we have found this to be markedly influenced by the animal's environment [8] Data concerning long term administration of oplold agonlsts and antagonists on food intake and body weight are few and confusing Chronic naltrexone infusions decreased food Intake in rats fed chow plus a 32% sucrose solution 1Requests for reprints should be addressed to Allen S Levlne, Ph D, Research Service (151), VA Medical Center, 54th St & 48th Ave S , Mmneapohs, MN 55417 better than m those ingesting only chow [16] Repeated lnjectmns of a zinc tannate preparatmn of naloxone decreased food retake only In rats receiving a high fat cafeteria diet [15] In a group of lean and obese Zucker rats, the long-acting oplold antagonist, nalmefene (6-desoxy-6 methylene naltrexone), decreased food intake but only slightly altered body weight [ll,12] On the other hand it has been reported that mice gain weight when g~ven naloxone and decrease their food retake after chromc morphine administration [26] In long term studies m humans naltrexone has been shown to shghtly decrease or have no effect on body weight [1, 17] The effect of chromc admlmstratlon of oplolds and their antagonists on food mtake and body weight m dmbetlc vs non-dmbetlc rats Is not known In the present study we addressed this issue by injecting the oplold agonlst, morphine, and the oplold antagonist, nalmefene, in a group of streptozotocm-lnduced dmbet~c rats and non-dmbet~c rats of the same strain for a period of 24 days while measuring food intake and body weight Nalmefene is potent and long lived relative to naloxone and does not possess as much oplold agonlst activity as naloxone [4] METHOD Male Sprague-Dawley rats were used for all studies and were housed under standard hghtlng and temperature conditions (12 hour/day artificml hght, 7 a m. to 7 p m , 25°C) Animals were gwen free access to Purina laboratory chow and to water At about 7 weeks of age rats were given an intravenous inJection (tad veto) of streptozotocln (55 mg/kg m 1 3% citric acid buffer, pH 4 5) followed by 2 ml of 30% dextrose Three weeks later they were bled vm the tail veto and glucose was measured using a Beckman Glucose Analyzer (Fullerton, CA) to assure a diabetic state (glucose=632+_22 mg/dl). Age-matched rats were used as non-diabetzc controls Food retake and body weight were quantified for 3 days before the start of the experimentation to acchmate the animals to handhng and daffy interruptions The rats were dlv]ded into five groups of ten and 1 group of eleven wh]ch allowed for three groups of dmbetlc and three groups of non-dmbetlc rats. To enable a balanced design for statistical analysis, one rat was omitted at random from the group containing eleven rats On day one of the study a single mject~on of either morphine sulfate (10 mg/kg, Eh Lilly and Co., Indmnapolls, IN), nalmefene (10 mg/kg, kindly prowded by Key Pharmaceuticals, Inc, Miami, FL) or vehicle was rejected subcutaneously Food retake was then measured at hours 1, 2, 4, 6 and 24. Durmg the ensuing 21 days, rats were reJected twice per day at about 0900 and 1600 hr On days 2 and 7 tood mtake was agam quantified at hours 1, 2, 4 and 6 (only 4 hour data are presented) Food retake and body weight were measured on days 3, 5, 10, 12, 15, 17, 19, and 22 Food intake was corrected for spdlage at each measurement and average dally intake was calculated by dividing the total food intake by the representative time period (eg grams eaten between (day 3/day 5)/3) Ammals were sacrificed on day 24 following one rejection of the appropriate drug and trunk bood was collected for analysis of glucose with a glucose ox~dase procedure (S~gma Chemical Co., St Lores, MO)
All data are shown as mean+_SEM Data were analyzed by analys~s of variance (ANOVA) (repeated measures when appropriate). Post-hoc tests (least s~gmficant dtfference procedure-LSD) were only conducted ff the overall ANOVA demonstrated an interaction The error term for each posthoc test was calculated by a one factor ANOVA At sacrifice, trunk blood was sampled and serum was analyzed for glucose concentration Serum glucose levels in diabetic and non-diabetic animals were not altered following chronic injections of morphine or nalmefene (DlabeUc sahne=530_ + 14, morphine=496_2, nalmefene=511 +_8 mg/dl) (Non-Diabetic saline= 142_+3, morphine= 138+_2, nalmefene = 148_+5 mg/dl)
Short-Term Feedmg Studle~
The effect of morphine and nalmefene on food mtake m diabetic and non-diabetic control rats on day 1, day 2 and day 7 was analyzed by a 3-factor repeated measures ANOVA There were main effects of diabetic state, F(1,54)=11 72, of drug, F(2,54)--22 53, and of day of the study, F(2,108)=5 25 (all p's<0 01) Also, there was a significant diabetic state x drug x day interaction Individual group comparisons (LSD procedure) mdlcated that morphine stimulated 4 hour food mtake in the non-diabetic rats on days 1, 2, and 7, whereas morphme only stimulated food intake in the dmbetlc rats on day 7 (F~g 1) Nalmefene had no significant effect on 4 hour food intake, although the mean Intakes after nalmefene were consistently less than control means Twenty-four hour food intake was s]gmficantly decreased m both d]abet]c and non-diabetic ammals following one injection (day 1) and following three reJections (day 1 + day 2) of morphine and nalmefene (Fig 2) 
Chrontc Drug Studtes
The effect of morphine and nalmefene on average food retake and on body weight change over 22 days was analyzed by a 3-factor repeated measures ANOVA There were mam effects of dmbetlc state, F(1,54)=846 93, of drug, F(2,54)= 9.34, and of day, F(7,378)=39 16 (allp's<0 001). There was a s]gmficant dmbeUc × drug mteractton, F(2,54)=5 22, p<0 05, and a slgntficant dmbetlc × drug × day mteracUon, F(14,378)=2 86, p<0 001 One factor ANOVA followed by LSD tests indicated that food retake was decreased by nalmefene and morphine m the dmbetlc rats, whereas only morphine decreased feeding at some time points m the nondmbetlc control rats (Fig. 3) Analysis of body weight data demonstrated main effects of diabetic state, F(1,54)=78 42, p<0 001, and of day F(8,432)=63 85, p<0.001, but not of drug There was a slgmficant interaction of dtabeUc state × drug × day, F(16,432)=1.814, p<0.05. One factor ANOVA followed by the least slgnLfiCance d]fference test indicated that body weight was reduced due to morphine rejection only m the non-dmbetlc ammals (Fig. 4 ) Nalmefene failed to alter mean body weight m either group of rats Analysis of maxtmum percent body weight gain (maximum weight gaan or at least a negative weight change/initial body weight × 100) and maximum percent body weight loss (maximum weight loss or at least a negatwe weight change/initial body we~ght×100) substantmted the observaUon that morphine has a more potent effect in non-dmbet~c controls compared w~th diabetic rats (Fig. 5) In the non-dmbet~c rats the maximum percent body 
FIG 4
The effect of chronic injection of morphine (10 mg/kg) and nalmefene (10 mg/kg) on body weight in dmbetlc (D) and nondlabettc (ND) rats *p<0 05 compared to sahne controls for rats of same day and dmbet~c status weight lost by the rats treated with morphine was approximately 15%, in contrast to only above a 5% maximum body weight loss m the dmbet~c rats To integrate food retake and body weight data we calculated a "feed effioency ratio" (change m body weight [e]ther (+) weight gain or (-) weight loss] from day 0 dwlded by the cumulative amount of food eaten) Morphine decreased the feed efficiency ratio m dmbeUcs as well as non-dmbetlcs, but had a more potent effect in the non-dmbetlc group (drug × dmbeUc state lnteractmn F(2,54)=3 432,p<0.05 (Fig. 6) In contrast, nalmefene failed to alter the feed efficiency ratto In non-dmbetlcs, but did so m the dmbet~cs DISCUSSION This study indicates that diabetic rats respond differently than non-dlabet~c control rats to the acute effects of morphine on food mtake as well as to the changes in food retake and body weight which occur followmg chrome morphine administration Morphine failed to stimulate short term food retake m diabetic animals following an lnmal exposure, whereas morphine stimulated feeding m non-dmbet]c controls rats after a single injection This might be secondary to the increased basal retake of food m the diabetics smce oplolds are less potent stimulators of feeding mammals chromcally food depraved [19] or during the nocturnal feedlng period [22] . However, repeated exposure of diabetic Sal Mar Nal Non-Diabetic animals to morphine ultimately resulted in enhanced food intake We have previously reported this "reversetolerance" effect in normal ammals [22] Nalmefene faded to alter short term food consumption m either group of rats, probably due to a floor effect In contrast to the short term studies, chronic administration of morphine to both dmbetlc and non-diabetic rats resulted m decreased cumulative food intake Also, morphine resulted in a more marked decrease in body weight in the non-dmbetlc animals The feed efficiency ratios also substantiated the latter finding, suggesting that diabetic rats were somewhat resistant to morphine's effect on energy balance The above data are in concordance with those reported by Simon and his colleagues [29, 30] They found that streptozotocln-mduced diabetic rats were less senslt~ve to the antlnooceptlve effects of morphine Recent data from the same laboratory indicates that hyperglycemia modifies the responses of guinea pig ileum and mouse vas deferens responses to normorphme [4.5] Prehmmary studies [31] indicate that glucose can enhance the bmdlng of naloxone to bram membranes It has also been shown that dmbetlc humans display decreased pare thresholds and pare tolerance [22] In general, tt appears that dmbetlc ammals respond differently to the effects of morphine on both pam and food intake when compared to non-diabetic control ammals
Relatively few studies have examined the effect of chromc admlmstratlon of oplold agomsts or antagonists on food intake and body weight In our study the long-acting oplold antagonist, nalmefene, faded to alter body weight m either dmbetlc or non-diabetic rats Nalmefene did not decrease food intake m the non-dmbetic rats, but did decrease food intake shghtly in the diabetic rats McLaughhn and Bade [11] found that nalmefene decreased meal size and dally food intake, but increased meal frequency m Zucker rats and their lean httermates Body weight decreased dunng the first week of the study m the nalmefene treated animals compared with the sahne treated controls, however, subsequent weight gain was greater in the nalmefene treated rats The weight loss was more marked m the obese Zucker rats Thus, McLaughhn and Bade [11 ] found only slight effects of nalmefene on body weight Naltrexone, when given twice a day at 10 mg/kg to genetically obese (ob/ob) mice decreased the rate of weight gain in these obese mice but had no effect on their lean httermates [23] From the latter studies ~t seems that op~old antagonism seems to affect energy balance more readily in obese animals Similarly, It appears that oplold antagonism is more potent in animals fed palatable foods Repeated injections of a zinc tannate preparation of naloxone abolishes diet-reduced obesity m rats fed a high fat cafeteria diet, whereas no effect of oploid blockade was noted in rats fed a low fat diet [15] Chromc naltrexone infusions (200 p.g/kg/hr) decreased appetite more effectively m rats fed chow plus 32% sucrose compared to those fed chow alone [16] Brands et al [2] also found that a zinc tannate salt of naloxone only decreased food intake during the first few days of the study and body weight during the first ten days of the study Shimomura et al [26] reported that lean mice given dady morphine injections decreased food retake McLaughhn and Baile [12] reported that rats autolmmumzed against fl-endorphin increase both their food retake and body weight This suggests that chronically available endogenous fl-endorphm might result in a decrease m food retake and body weight Thls finding is m keeping with our previous study showing that peripherally infused beta-endorphm decreased food retake [18] The present study indicates that normal rats chromcally treated with morphine lose weight and ingest somewhat less food suggesting that morphine's effect on body weight could be due to increased energy expenditure, rather than secondary to its effects on feeding Also, nalmefene faded to decrease body weight in dmbetlc ammals, although food retake was decreased However. it is difficult to generahze these effects of morphine and/or fl-endorphm to all oplolds 
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FIG 6
The effect of chronic admmlstraUon of morphine (10 mg/kg bid) and nalmefene (10 mg/kg bid) on feed efficiency in diabetic and non-diabetic rats +p<0 05 for rats of same day and diabetic status
The decreased feed efficiency noted with chronic inJection of morphine suggests an effect on energy conservation Morphine seems to have decreased body weight to a greater extent than can be accounted for by food intake alone, particularly in the non-dmbetlc animals Chronic naloxone rejection has been reported by several investigators to increase oxygen consumption [14, 15] However, Marks-Kaufman et al [16] found that although naltrexone treatment altered the respiratory quotient, it had no effect on total oxygen consumption Oplolds are also known to affect hpld metabolism For example, Richter et al [24] demonstrated that /3-11potropm stimulated hpolysls in rabbits Thus, the present data indicate that morphine, when injected chromcally, can alter body weight The effect of morphine on body weight is different in dmbetic animals when compared to non-diabetic controls In general, diabetic animals appear to be less sensitive to the acute effects of morphine on food intake and the effects of chromc administration of morphine on body weight
